News at Geistlich Pharma AG

2019 · 2018 · 2017 · 2016 · 2015 · 2014 · 2013 ·
  • A gain of 6.5 mm and 5.5 mm of vertical and horizontal bone, respectively. 100 % implant survival after a mean follow-up of 12 months.1 Yxoss CBR®, exclusively marketed by Geistlich, is the groundbreaking product you have been waiting for.

  • On our blog: A chat with Jung-Chul Park

    He publishes videos under the title «Back to the suture», uses social media for educational purposes and has learned a lot from card and coin tricks for his lectures - we met Prof. Jung-Chul Park for an entertaining and insightful interview.


    > Read more

  • On our blog: “It’s not only science. There is a lot of art involved.”

    Geistlich invested heavily to develop its latest product, the 3D collagen matrix Geistlich Fibro-Gide®. Dr. Terance Hart, Director Research, and Dr. Mark Spilker, Chief Scientific Officer, talk about innovation, research pathways and strategic collaborations.


    Read more

  • Despite sinus floor elevation being a technique invented more than 30 years ago, there remain several outstanding questions on how to optimally balance minimal invasiveness and reliable bone regeneration. The new treatment concept brochure “Sinus Floor Elevation” sheds light on decision criteria, recent scientific findings and long-term results.

  • Our experts discuss “minimally invasive approaches” – tailored to regenerative therapies. A few highlights from the current issue of Geistlich News.

  • On our blog: A breakthrough in soft-tissue regeneration

    ”As a clinician and researcher I believe that the new volume-stable collagen matrix is a breakthrough in soft tissue regeneration” says PD Dr Daniel Thoma, Zurich. Read more on our regeneration expert blog

    > Read More

  • Once again two excellent speakers will make the Geistlich Corporate Session at the Europerio 2018 an indispensable event. PD Dr. Daniel Thoma and Prof. Giovanni Zucchelli will be sharing their experiences with the new volume-stable collagen matrix Geistlich Fibro-Gide®; at 12.30 pm on Thursday, 21 June. The new device has delivered convincing results in both soft-tissue volume augmentation and recession coverage.

  • On our blog: Augmentation procedures for geriatric patients: How to manage risks

    Visit our regeneration expert blog now and discover more about how to manage risks during augmentation procedures for geriatric patients! Prof. Zhoufan Chen and Dr. Zhipeng Li, China, share with us which key factors need to be considered for a successful treatment!

    > Read More

  • On our blog: Heart renewal in newts

    Focus on regeneration: When newts lose a leg, they regenerate a new one. Even destroyed cardiac tissue is swiftly replaced by healthy tissue. What is the underlying mechanism and what can we learn from it? Discover more on our blog!

    > Read More

  • The foundation stone is laid for the “888plus” extension building at the Geistlich Pharma AG headquarters in Wolhusen. With this investment in the tens of millions, Geistlich demonstrates its commitment to its Switzerland location.

Dr. Mirjam Kessler
Director Corporate Communications
Verena Vermeulen
Scientific Communication Manager